Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

This study has been completed.

Study NCT00289536 Information provided by Baxter Healthcare Corporation

First Received: February 9, 2006 Last Updated: July 24, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2008
Estimated Primary Completion Date:	No date given